secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXOZYMES INC. (EXOZ)
CIK:        0002010788
Form:       8-K
Filed at:   2025-07-28T23:59:59+00:00
Accession:  0001641172-25-021084
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

eXoZymes shareholders elect all six director nominees, approve compensation and 2025 equity plan at annual meeting
--------------------------------------------------------------------------------

- All six director nominees (Marlett, DiGiandomenico, Bowie, Lalonde, Bell, Rayo) elected with at least 4.25M votes for.
- Non-binding advisory resolution on executive compensation approved: 4,272,987 for, 1,801 against.
- Shareholders voted for a three-year frequency of future advisory votes on executive compensation (4,121,899 for three years).
- 2025 Performance Equity Plan approved: 4,181,189 for, 92,840 against.
- Ratification of RBSM LLP as auditor for FY2025 received 4,779,589 votes for; quorum was 56.98%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2010788/000164117225021084/0001641172-25-021084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2010788/000164117225021084/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-021084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer